News Detail
Netherlands, 23 Aug 2023: A new antibiotic, isolated from bacteria that are unculturable, seems capable of combating harmful bacteria and even multi-resistant “superbugs.” The new drug, Clovibactin, efficiently killed drug-resistant Gram-positive bacterial pathogens. ......
View Details
Source : Genetic Engineering and Biotechnology News
new antibiotic
Clovibactin
discovery of new antibiotic
all about clovibactin
antibiotic resistance
Antibiotics
uncultured bacteria
peptidoglycan
cell wall
lipid II
mechanism of action
solid state NMR
atomic force microscopy
antibiotic resistance
infection
animal models
Related News
- Zydus gets warning as FDA highlights glass contamination concerns and others (12-09-2024)
- MPIDC allotted land to 36 industries in Medical Devices Park, investment of 1.8k crore (12-09-2024)
- DCC asks states and UTs to ensure implementation of revised Schedule M (12-09-2024)
- NPPA fixes retail price of 62 new drugs, extends CP of knee implants (12-09-2024)
- US FDA Issues Revised Guidance On Controlling Nitrosamine Impurities In Pharmaceuticals (12-09-2024)
- Bharat Biotech collaborates with US-based Alopexx to develop antimicrobial vaccine (12-09-2024)
- DCGI suspends permission to Entod pharma's 'Presvu Eye Drops', company to challenge order in court (11-09-2024)
- Diagnostic kits for early detection of Alzheimer’s and cancer launched (11-09-2024)
- FDI equity inflow into pharma sector grows to $236 million in Q1FY25 (11-09-2024)
- Steroid Use Could Raise Diabetes Risk (11-09-2024)